ESC 365 - Risk factor modification and pharmacotherapy to prevent thoracic aneurysm progression.

ESC Premium Access

Risk factor modification and pharmacotherapy to prevent thoracic aneurysm progression.

Session: Clinical issues in thoracic aortic disease

Topic: Diseases of the Aorta

Speaker: Professor P. Jankowski (Warsaw, PL)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Piotr Jankowski

The Medical Centre of Postgraduate Education, Warsaw (Poland)

10 presentations

0 follower

3 more presentations in this session

Thoracic aortic aneurysms: more than one disease

Speaker: Professor G. Jondeau (Paris, FR)

Aortic dilatation in the young and the pregnant.

Speaker: Doctor M. Bissell (Leeds, GB)

Treatment of thoracic aortic diseases: when endovascular, when open surgery?

Speaker: Professor M. Czerny (Freiburg, DE)

Access the full session

Clinical issues in thoracic aortic disease

Speakers: Professor P. Jankowski, Professor G. Jondeau, Doctor M. Bissell, Professor M. Czerny

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources